CDEK
← All organizations

Zafgen, Inc.

For profitWebsite ↗

Also known as: Zafgen, Inc.

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Dec 1, 2009

Last known activity

Sep 12, 2017

Acquired by Larimar Therapeutics → Zafgen, Inc. → Larimar Therapeutics → Zafgen, Inc. → Larimar Therapeutics → Zafgen, Inc. → Larimar Therapeutics → Zafgen, Inc. → Larimar Therapeutics → Zafgen, Inc. → Larimar Therapeutics → Zafgen, Inc. → Larimar Therapeutics → Zafgen, Inc. → Larimar Therapeutics → Zafgen, Inc. → Larimar Therapeutics → Zafgen, Inc. → Larimar Therapeutics → Zafgen, Inc. → Larimar Therapeutics → Zafgen, Inc. → Larimar Therapeutics → Zafgen, Inc. → Larimar Therapeutics on May 15, 2020

Timeline

2000s

  1. Jun 1, 2005

    Zafgen, Inc.— Founded

2010s

  1. Dec 19, 2019

    Larimar Therapeutics— Acquired

2020s

  1. May 15, 2020

    Larimar Therapeutics— Acquired By

  2. May 15, 2020

    Larimar Therapeutics— Now

Drugs by trial phase (4 distinct, 14 trials)

Phase 3 (0 own, 1 via acquisition)

Phase 2 (0 own, 2 via acquisition)

Phase 1 (0 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 25 total across the full acquisition tree)

Recent trials (13)

Details

Founded
Boston, MA, US Jun 1, 2005
Last known activity
Sep 12, 2017